-
2023 Shenzhen Medical Fair
Time of Update: 2023-02-03
cn/shenzhen Address: Room 1003, Building A, Twin Buildings, No. 668 Xin Brick Road, Songjiang District, Shanghai Contact number: 18721265877 Contact WeChat: shenzhenexpo Contact person: Mr. Shen The 40th Shenzhen International Medical Equipment Exhibition 2023 will be held in Shenzhen World Exhibition and Convention Center on August 29-31, covering medical electronics and medical film Like equipment, intelligent medical care, ward nursing and auxiliary equipment, medical dressings, in vitro diagnostic reagents, optical first aid, rehabilitation nursing and medical informatization, etc.
-
Arkema launches medical-grade bio-based PA11 material
Time of Update: 2023-01-17
Rilsan MED PA11 is based on the company's flagship product and is part of Arkema's portfolio of advanced bio-based recyclable materials .
5GPa Rilsan MED PA11 is formulated with 65% glass fibers to achieve a tensile modulus of 18.
-
The EU CLP regulation will add a new hazard classification of "endocrine disruptors
Time of Update: 2023-01-07
(Source: Ruio Technology) On 20 September, the amendments to Regulation (EC) No 1272/2008 (CLP Amendment) opened a final four-week public comment period, which closed on 18 October.
-
The US medical and health organization recommends strengthening the new crown vaccination Japan's vaccination rate reaches 81.4
Time of Update: 2023-01-05
According to data from the official website of the World Health Organization, as of 17:12 CET on the 21st, the number of new confirmed cases of new crowns in the world reached 68,230 in a single day, with a cumulative total of 634522052 confirmed cases; There were 256 new deaths, bringing the total to 6,599,100.
-
Refinement of medical insurance services to enhance people's sense of gain
Time of Update: 2022-11-14
js?cdnversion='+~(-new Date()/36e5)];Medical insurance departments across the country actively open up various payment channels, and urban and rural residents can pay offline at bank business outlets, or pay online through local tax mini programs, Alipay citizen center social security payments, bank APP, etc.
-
A number of pharmaceutical companies ran out of "acceleration" in the first three quarters! In the fourth quarter, the pharmaceutical sector is still optimistic about brokers
Time of Update: 2022-10-20
The market situation of the sector in the fourth quarter is still optimistic about brokerages In the long run, many securities firms, including Deppon Securities, Soochow Securities, and Kaiyuan Securities, still expressed their optimism about the market of the pharmaceutical sector in the fourth quarter, and suggested paying attention to the tracks of traditional Chinese medicine, consumer medical care, innovative drugs, and medical devices in the sub-sectors.
-
Nutritional management and treatment can also be carried out at home for cancer patients
Time of Update: 2022-09-20
Specifically, in addition to the unified energy intake of 25-35 kcal/(kg·day), 50%-65% carbohydrate energy supply, more than 50% high-quality protein, and 20%-35% dietary fat energy supply, the 2022 version of the consensus also increased the protein intake of patients with no obvious abnormalities in liver and kidney function in the cancer recovery period, from 1.
-
Ding Gangqiang, Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention: Improving nutritional status is the basis and guarantee for enhancing immunity
Time of Update: 2022-09-05
At the meeting, Ding Gangqiang, director of the Institute of Nutrition and Health of the Chinese Center for Disease Control and Prevention, delivered a keynote speech on "Nutrition Problems and Intervention Countermeasures in the New Situation - The Cornerstone of Reasonable Diet and Immunization" .
-
In order to increase the layout of the traditional Chinese medicine industry, many pharmaceutical companies plan to acquire and merge
Time of Update: 2022-08-19
Recently, Wanbangde said in an investor survey that in the future, the company's pharmaceutical manufacturing sector will focus on the traditional Chinese medicine industry, jointly develop traditional Chinese medicine products, sort out the existing 24 traditional Chinese medicine products and carry out secondary research and development, and will not rule out acquisitions and mergers to enrich traditional Chinese medicine.
-
Nearly 400 A-share listed companies received institutional research this month, and pharmaceutical biology is still "hot
Time of Update: 2022-05-08
. Judging from the individual stocks surveyed, Mindray Medical ranks first in institutional research, with a total of 554 institutions surveying the company in March .
In 2021, Mindray Medical's revenue from the new domestic medical infrastructure sector will be about 3 billion yuan .
-
Lepu Medical's novel coronavirus antigen detection kit obtained product registration certificate
Time of Update: 2022-04-29
On March 14, 2022, Lepu Medical announced that the new coronavirus antigen detection kit (colloidal gold method) developed by the company's holding subsidiary Lepu Diagnostics was approved by NMPA on
-
The State Food and Drug Administration approved the registration of 208 medical device products in January
Time of Update: 2022-03-02
On February 18, the State Food and Drug Administration announced that a total of 208 registered medical device products will be approved in January 2022 .
-
Major revision
Time of Update: 2022-02-24
On the basis of formulating the "Medical Waste Classification Catalog", the National Health Commission also formulated the "Medical Waste Exemption Management List" (hereinafter referred to as the "List") .
-
Ther Adv Musculoskelet Dis: Epidemiology and risk of invasive fungal infection in systemic lupus erythematosus
Time of Update: 2022-02-17
In conclusion, this nationwide population-based cohort study revealed a high risk of IFI infection and mortality in patients with lupus erythematosus, including a high risk in juvenile lupus erythematosus patients .
-
The market for inhalation preparations is booming, and many pharmaceutical companies have completed billions of yuan in financing during the year
Time of Update: 2021-10-21
Public information shows that Changxi Pharmaceutical is a clinical stage biomedical company for the discovery, development and industrialization of new drugs that seriously affect the quality of human daily life, including respiratory diseases, and has patent-protected dry powder preparation technology and Efficient and convenient inhaler technology .
